
Almena Free MD CCRP
Hospital Medicine/Hospitalist
Vice President of Medical Affairs/Chief Medical Officer, Regional Medical Center and Stringfellow Hospital Medical Director and principal investigator Pinnacle Research Group Medical director Self Recovery detox
Join to view full profile
400 E Tenth St301 E 19th StAnniston, AL 36207
Phone+1 256-235-5959
Dr. Free is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationResidency, Internal Medicine, 1993 - 1996
Morehouse School of MedicineClass of 1993
Certifications & Licensure
AL State Medical License 1996 - 2026
OH State Medical License 1995 - 1996
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts Professional EHR, Allscripts, 2013-2016
- CMS Meaningful Use Stage 1 Certification Allscripts MyWay EHR, Allscripts, 2013-2016
Clinical Trials
- Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)
- Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets
- Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Publications & Presentations
PubMed
- Effects of renal impairment on the pharmacokinetics, safety, and tolerability of pudexacianinium (ASP5354) after IV administration: a mechanistic exploration.Tomoki Kojima, Masako Saito, Toshihiro Matsuda, Neal Simmons, Masanori Nagata
European Journal of Clinical Pharmacology. 2026-04-25 - Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with ...Anil Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, Moti Ramgopal, Almena Free
Drugs in R&D. 2025-12-01 - 13 citationsIntramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial.Adrienne E Shapiro, Elias Sarkis, Jude Acloque, Almena Free, Yaneicy Gonzalez-Rojas
Open Forum Infectious Diseases. 2023-08-01
Press Mentions
RMC Cuts Ribbon on New Clinic Aimed at Easing Patients’ Path HomeJanuary 15th, 2026
Dr. Almena Free Urges Early Prevention, Screenings to Curb Mounting Chronic Disease BurdenDecember 2nd, 2025
Family, Colleagues Dedicate Heart Lab at RMC in Memory of DoctorJuly 11th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









